A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

An experimental medication was shown to achieve strong pain relief in early studies without the risks associated with typical opioids. The finding comes from the National Institute on Drug Abuse (NIDA ...

More good news in the battle against opioid addiction. Scientists have reopened research into a class of opioids that were once shelved from study — and have discovered a variant that’s a powerful ...

Prescriptions for the new non-opioid pain medication suzetrigine more than doubled between April and August 2025, according to analysis from Epic Research. The increase indicates a growing interest in ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug, suzetrigine, ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time in over two decades that the agency has approved a non-opioid pain drug ...

Opioid antagonists are medications people can take to treat opioid use disorder. They help by reducing withdrawal symptoms, addressing cravings, and managing overdoses. Doctors prescribe opioid ...

The FDA has also required a prospective, randomized clinical trial to examine the benefits and risks of long-term opioid use. The FDA is requiring safety labeling changes to all opioid painkillers, to ...